Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 11,801 | 0 | N/A |
| TOTAL | $12,161 | $0 | $N/A |
| Non-Current Assets | |||
| PPE Net | 39 | 0 | N/A |
| Other Non-Current Assets | 117 | 0 | 0 |
| TOTAL | $156 | $N/A | $N/A |
| Total Assets | $12,317 | $0 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 1,906 | 0 | N/A |
| Accounts payable and accrued liabilities | 931 | 0 | 0 |
| Accrued Expenses | 975 | 0 | N/A |
| Other current liabilities | 1,182 | 0 | N/A |
| TOTAL | $4,994 | $0 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 5,308 | 0 | N/A |
| TOTAL | $5,308 | $N/A | $N/A |
| Total Liabilities | $10,302 | $0 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | 0 | N/A |
| Retained earnings | -43,073 | 0 | N/A |
| Other shareholders' equity | 28,346 | 0 | 0 |
| TOTAL | $2,015 | $0 | $N/A |
| Total Liabilities And Equity | $12,317 | $0 | $0 |